The risk of MASLD in moderate-to-severe psoriasis is primarily linked to the inflammatory process, which induces pro-inflammatory cytokines such as interleukin (IL)-6, tumor necrosis factor (TNF)-α, and leptin. Here, TNF is linked to psoriasis.